Ritlecitinib

A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo

A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS.

Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the US

Double Blind, Placebo-controlled Trial to Establish Safety and Efficacy of Ritlecitinib in Celiac Disease Patients in Remission

A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2

A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) Tranquillo

Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib

Ritlecitinib (PF-06651600) in Participants With Chronic Spontaneous Urticaria

Pre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600)

Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D)

Ritlecitinib in Patients With Keloids or Those Undergoing Keloidectomy

A Study to Learn About the Medicine Called Ritlecitinib in Adults With Severe Alopecia Areata in Real-world Settings

Ritlecitinib in CTCL

A Study to Learn About Three Forms of The Study Medicine (Ritlecitinib) in Healthy Adults

A Study to Assess Two Forms of The Study Medicine (Ritlecitinib) in Healthy Adult Participants

A Study to Learn About How Different Forms of the Study Medicine Called Ritlecitinib Pass the Intestines of Healthy Male Adults When Taken With or Without Food

Efficacy and Safety of JAK Inhibitors in Patients With AA: RWE Study

Study to Evaluate the Effect of Multiple-Dose Ritlecitinib on the Pharmacokinetics (PK) of Tolbutamide

A Single Dose Study To Test Two Pediatric Forms Of Ritlecitinib Compared With Adult Ritlecitinib In Healthy Adults

Estimation of the Effect of Multiple Dose Ritlecitinib (PF-06651600) on the Pharmacokinetics of a Single Dose of Caffeine in Healthy Participants